Share Price and Basic Stock Data
Last Updated: January 3, 2026, 11:53 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Max India Ltd operates primarily as a holding company, with a market capitalization of ₹985 Cr and a share price of ₹188. The company’s revenue has shown volatility over recent quarters, with sales reported at ₹58 Cr in September 2022, declining to ₹41 Cr by June 2023, and fluctuating between ₹41 Cr and ₹56 Cr thereafter. For the trailing twelve months (TTM), sales stood at ₹158 Cr, indicating a downward trend compared to previous fiscal years, where sales were ₹212 Cr in FY 2023 and ₹229 Cr in FY 2022. The company reported expenses that outpaced revenue, reaching ₹287 Cr for the TTM, which exacerbated its financial difficulties. This trend highlights the challenges Max India faces in maintaining stable revenue generation amidst increasing costs and operational inefficiencies.
Profitability and Efficiency Metrics
Max India Ltd’s profitability metrics reflect significant challenges, with an operating profit margin (OPM) of -69%, underscoring the company’s struggle to generate positive returns from its operations. The company recorded a net profit of -₹150 Cr for the TTM, following a pattern of losses over the past several financial years, including a net loss of ₹10 Cr in FY 2023 and ₹16 Cr in FY 2022. The interest coverage ratio (ICR) stood at -12.39x, indicating that the company’s earnings are insufficient to cover its interest obligations. The return on equity (ROE) was reported at 30.0%, driven primarily by the equity capital of ₹44 Cr, but this figure masks the underlying operational inefficiencies. The cash conversion cycle (CCC) was -111 days, suggesting that the company may be facing liquidity issues, thereby impacting its operational efficiency and sustainability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Max India Ltd reveals a mixed picture of financial health. The company reported reserves of ₹415 Cr, down from ₹652 Cr in FY 2020, indicating a significant depletion of shareholder equity over the years. Borrowings increased to ₹204 Cr as of September 2025, reflecting a growing reliance on debt, which raises concerns about financial sustainability. The total assets stood at ₹838 Cr, with fixed assets reported at ₹166 Cr, suggesting limited capital investment in growth initiatives. Financial ratios such as the price-to-book value (P/BV) stood at 2.24x, indicating that the stock is valued higher than its book value, which may not be justified given the company’s performance. The current ratio was reported at 2.15x, which is generally considered healthy, but the overall financial metrics raise caution regarding the company’s ability to navigate future challenges.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Max India Ltd reflects a significant concentration of ownership, with promoters holding 50.06% of the shares, while foreign institutional investors (FIIs) accounted for 7.08% and domestic institutional investors (DIIs) held 1.43%. The public shareholding was recorded at 41.45%, with a total of 39,796 shareholders, indicating a relatively stable investor base. The promoter holding has seen a slight decline from 51.11% in December 2022 to 50.06% in September 2025, potentially signaling a gradual dilution of control. The decreasing stake of FIIs, from 11.38% in December 2022 to 7.08%, raises questions about investor confidence in the company’s future prospects. This pattern of shareholding could affect the company’s strategic decisions and ability to attract further investment.
Outlook, Risks, and Final Insight
The outlook for Max India Ltd appears challenging, given its recent financial performance and operational inefficiencies. The persistent losses, as evidenced by the net profit of -₹150 Cr, coupled with a negative interest coverage ratio, indicate that the company must urgently address its cost structure and operational strategies. Risks include the reliance on debt financing, which could strain cash flows, and declining revenues that hinder growth prospects. On the other hand, strengths such as a high ROE of 30.0% and a substantial reserve base could be leveraged for restructuring and potential recovery. If the company can stabilize its operations and improve profitability, there could be a pathway to recovery, but without significant changes, the risks of continued underperformance remain high.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Choice International Ltd | 18,943 Cr. | 850 | 852/438 | 104 | 59.5 | 0.00 % | 20.0 % | 19.6 % | 10.0 |
| Abans Holdings Ltd | 1,025 Cr. | 202 | 289/165 | 8.38 | 233 | 0.00 % | 9.71 % | 10.2 % | 2.00 |
| Max India Ltd | 985 Cr. | 188 | 264/160 | 89.4 | 0.00 % | 23.6 % | 30.0 % | 10.0 | |
| IDFC Ltd | 17,275 Cr. | 108 | / | 19.9 | 83.6 | 0.93 % | 8.49 % | 8.37 % | 10.0 |
| BF Investment Ltd | 1,576 Cr. | 419 | 682/395 | 19.2 | 1,880 | 0.00 % | 4.62 % | 3.39 % | 5.00 |
| Industry Average | 69,990.71 Cr | 2,140.86 | 33.78 | 1,274.21 | 0.26% | 12.46% | 13.71% | 6.86 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 58 | 43 | 56 | 41 | 49 | 41 | 45 | 26 | 43 | 35 | 42 | 37 | 45 |
| Expenses | 56 | 46 | 55 | 53 | 54 | 58 | 66 | 54 | 64 | 64 | 82 | 65 | 76 |
| Operating Profit | 2 | -3 | 1 | -12 | -5 | -17 | -21 | -28 | -21 | -30 | -41 | -28 | -31 |
| OPM % | 4% | -7% | 2% | -31% | -9% | -43% | -46% | -106% | -49% | -85% | -98% | -76% | -69% |
| Other Income | 3 | 3 | 4 | 6 | 6 | 5 | 5 | 6 | 5 | -8 | 4 | 13 | 5 |
| Interest | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 4 | 4 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 5 | 5 | 6 | 6 |
| Profit before tax | 2 | -4 | 1 | -10 | -2 | -17 | -20 | -27 | -22 | -44 | -45 | -25 | -36 |
| Tax % | 208% | -93% | 388% | 19% | 160% | 8% | 6% | 0% | 3% | 0% | 2% | 4% | -5% |
| Net Profit | -2 | -0 | -4 | -12 | -5 | -18 | -22 | -27 | -23 | -45 | -46 | -26 | -34 |
| EPS in Rs | -0.34 | -0.05 | -0.82 | -2.38 | -0.91 | -3.48 | -4.20 | -5.25 | -4.42 | -8.68 | -8.88 | -4.91 | -6.52 |
Last Updated: December 30, 2025, 12:36 am
Below is a detailed analysis of the quarterly data for Max India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 45.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Jun 2025) to 45.00 Cr., marking an increase of 8.00 Cr..
- For Expenses, as of Sep 2025, the value is 76.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 65.00 Cr. (Jun 2025) to 76.00 Cr., marking an increase of 11.00 Cr..
- For Operating Profit, as of Sep 2025, the value is -31.00 Cr.. The value appears to be declining and may need further review. It has decreased from -28.00 Cr. (Jun 2025) to -31.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Sep 2025, the value is -69.00%. The value appears strong and on an upward trend. It has increased from -76.00% (Jun 2025) to -69.00%, marking an increase of 7.00%.
- For Other Income, as of Sep 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Jun 2025) to 5.00 Cr., marking a decrease of 8.00 Cr..
- For Interest, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 4.00 Cr..
- For Depreciation, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 6.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -36.00 Cr.. The value appears to be declining and may need further review. It has decreased from -25.00 Cr. (Jun 2025) to -36.00 Cr., marking a decrease of 11.00 Cr..
- For Tax %, as of Sep 2025, the value is -5.00%. The value appears to be improving (decreasing) as expected. It has decreased from 4.00% (Jun 2025) to -5.00%, marking a decrease of 9.00%.
- For Net Profit, as of Sep 2025, the value is -34.00 Cr.. The value appears to be declining and may need further review. It has decreased from -26.00 Cr. (Jun 2025) to -34.00 Cr., marking a decrease of 8.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -6.52. The value appears to be declining and may need further review. It has decreased from -4.91 (Jun 2025) to -6.52, marking a decrease of 1.61.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:59 am
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 211 | 121 | 229 | 212 | 191 | 163 | 158 |
| Expenses | 216 | 150 | 232 | 202 | 229 | 264 | 287 |
| Operating Profit | -5 | -29 | -3 | 10 | -38 | -101 | -129 |
| OPM % | -2% | -24% | -1% | 5% | -20% | -62% | -82% |
| Other Income | 277 | 0 | 2 | 1 | 4 | -10 | 13 |
| Interest | 27 | 24 | 10 | 6 | 5 | 8 | 12 |
| Depreciation | 8 | 10 | 7 | 8 | 10 | 19 | 22 |
| Profit before tax | 237 | -64 | -18 | -3 | -49 | -139 | -150 |
| Tax % | 2% | -17% | -11% | 245% | 15% | 1% | |
| Net Profit | 232 | -53 | -16 | -10 | -56 | -140 | -150 |
| EPS in Rs | 29,706.00 | -8.30 | -2.52 | -2.03 | -10.97 | -27.05 | -28.99 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -122.84% | 69.81% | 37.50% | -460.00% | -150.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 192.66% | -32.31% | -497.50% | 310.00% |
Max India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -5% |
| 3 Years: | -11% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -88% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 32% |
| 3 Years: | 40% |
| 1 Year: | -10% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -9% |
| 3 Years: | -13% |
| Last Year: | -30% |
Last Updated: Unknown
Balance Sheet
Last Updated: December 4, 2025, 1:38 am
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 54 | 54 | 54 | 43 | 43 | 44 | 52 |
| Reserves | 652 | 599 | 588 | 499 | 449 | 315 | 415 |
| Borrowings | 182 | 145 | 61 | 45 | 44 | 102 | 204 |
| Other Liabilities | 136 | 198 | 156 | 166 | 148 | 172 | 167 |
| Total Liabilities | 1,024 | 996 | 858 | 753 | 684 | 633 | 838 |
| Fixed Assets | 144 | 156 | 159 | 159 | 193 | 170 | 166 |
| CWIP | 1 | 0 | 0 | 0 | 10 | 21 | 32 |
| Investments | 414 | 334 | 178 | 83 | 63 | 53 | 59 |
| Other Assets | 465 | 506 | 522 | 511 | 418 | 389 | 581 |
| Total Assets | 1,024 | 996 | 858 | 753 | 684 | 633 | 838 |
Below is a detailed analysis of the balance sheet data for Max India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 52.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2025) to 52.00 Cr., marking an increase of 8.00 Cr..
- For Reserves, as of Sep 2025, the value is 415.00 Cr.. The value appears strong and on an upward trend. It has increased from 315.00 Cr. (Mar 2025) to 415.00 Cr., marking an increase of 100.00 Cr..
- For Borrowings, as of Sep 2025, the value is 204.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 102.00 Cr. (Mar 2025) to 204.00 Cr., marking an increase of 102.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 167.00 Cr.. The value appears to be improving (decreasing). It has decreased from 172.00 Cr. (Mar 2025) to 167.00 Cr., marking a decrease of 5.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 838.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 633.00 Cr. (Mar 2025) to 838.00 Cr., marking an increase of 205.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 166.00 Cr.. The value appears to be declining and may need further review. It has decreased from 170.00 Cr. (Mar 2025) to 166.00 Cr., marking a decrease of 4.00 Cr..
- For CWIP, as of Sep 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 11.00 Cr..
- For Investments, as of Sep 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 6.00 Cr..
- For Other Assets, as of Sep 2025, the value is 581.00 Cr.. The value appears strong and on an upward trend. It has increased from 389.00 Cr. (Mar 2025) to 581.00 Cr., marking an increase of 192.00 Cr..
- For Total Assets, as of Sep 2025, the value is 838.00 Cr.. The value appears strong and on an upward trend. It has increased from 633.00 Cr. (Mar 2025) to 838.00 Cr., marking an increase of 205.00 Cr..
Notably, the Reserves (415.00 Cr.) exceed the Borrowings (204.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | -187.00 | -174.00 | -64.00 | -35.00 | -82.00 | -203.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 24 | 22 | 9 | 5 | 9 | 50 |
| Inventory Days | 1,736 | 6,544 | 385 | 223 | 38 | 186 |
| Days Payable | 154 | 633 | 28 | 48 | 148 | 346 |
| Cash Conversion Cycle | 1,607 | 5,932 | 366 | 180 | -100 | -111 |
| Working Capital Days | 438 | 500 | 343 | 249 | -99 | -93 |
| ROCE % | -4% | -0% | 1% | -8% | -24% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -32.50 | -13.08 | -2.18 | -3.35 | -9.88 |
| Diluted EPS (Rs.) | -32.50 | -13.08 | -2.17 | -3.35 | -9.88 |
| Cash EPS (Rs.) | -28.06 | -10.96 | -0.15 | -1.34 | -7.81 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 82.29 | 114.05 | 125.99 | 118.45 | 121.44 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 82.29 | 114.05 | 125.99 | 118.45 | 121.44 |
| Revenue From Operations / Share (Rs.) | 33.38 | 40.68 | 46.72 | 42.74 | 22.47 |
| PBDIT / Share (Rs.) | -22.91 | -8.20 | 3.00 | 1.17 | -3.72 |
| PBIT / Share (Rs.) | -27.23 | -10.55 | 1.04 | -0.49 | -5.65 |
| PBT / Share (Rs.) | -31.97 | -11.61 | -0.40 | -3.36 | -11.72 |
| Net Profit / Share (Rs.) | -32.38 | -13.31 | -2.12 | -3.01 | -9.73 |
| NP After MI And SOA / Share (Rs.) | -32.21 | -13.06 | -2.41 | -3.35 | -9.88 |
| PBDIT Margin (%) | -68.63 | -20.15 | 6.43 | 2.74 | -16.54 |
| PBIT Margin (%) | -81.57 | -25.93 | 2.22 | -1.16 | -25.12 |
| PBT Margin (%) | -95.77 | -28.53 | -0.86 | -7.86 | -52.13 |
| Net Profit Margin (%) | -97.01 | -32.71 | -4.53 | -7.04 | -43.31 |
| NP After MI And SOA Margin (%) | -96.49 | -32.10 | -5.16 | -7.84 | -43.94 |
| Return on Networth / Equity (%) | -39.14 | -11.45 | -1.91 | -2.83 | -8.13 |
| Return on Capital Employeed (%) | -25.37 | -8.34 | 0.75 | -0.38 | -3.93 |
| Return On Assets (%) | -22.18 | -8.23 | -1.37 | -2.11 | -5.32 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.04 | 0.06 | 0.13 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.04 | 0.06 | 0.13 |
| Asset Turnover Ratio (%) | 0.22 | 0.24 | 0.25 | 0.24 | 0.11 |
| Current Ratio (X) | 2.15 | 2.47 | 2.86 | 3.58 | 3.49 |
| Quick Ratio (X) | 2.05 | 2.43 | 2.54 | 2.73 | 2.38 |
| Inventory Turnover Ratio (X) | 12.78 | 0.46 | 0.04 | 0.02 | 0.01 |
| Interest Coverage Ratio (X) | -12.39 | -7.72 | 2.08 | 0.61 | -0.81 |
| Interest Coverage Ratio (Post Tax) (X) | -14.95 | -11.53 | -0.46 | -0.07 | -0.80 |
| Enterprise Value (Cr.) | 694.17 | 645.65 | 281.41 | 408.39 | 411.70 |
| EV / Net Operating Revenue (X) | 4.77 | 3.68 | 1.40 | 1.78 | 3.41 |
| EV / EBITDA (X) | -6.95 | -18.24 | 21.77 | 64.67 | -20.59 |
| MarketCap / Net Operating Revenue (X) | 5.51 | 4.86 | 1.75 | 1.73 | 2.86 |
| Price / BV (X) | 2.24 | 1.73 | 0.64 | 0.62 | 0.52 |
| Price / Net Operating Revenue (X) | 5.51 | 4.86 | 1.75 | 1.73 | 2.86 |
| EarningsYield | -0.17 | -0.06 | -0.02 | -0.04 | -0.15 |
After reviewing the key financial ratios for Max India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -32.50. This value is below the healthy minimum of 5. It has decreased from -13.08 (Mar 24) to -32.50, marking a decrease of 19.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is -32.50. This value is below the healthy minimum of 5. It has decreased from -13.08 (Mar 24) to -32.50, marking a decrease of 19.42.
- For Cash EPS (Rs.), as of Mar 25, the value is -28.06. This value is below the healthy minimum of 3. It has decreased from -10.96 (Mar 24) to -28.06, marking a decrease of 17.10.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 82.29. It has decreased from 114.05 (Mar 24) to 82.29, marking a decrease of 31.76.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 82.29. It has decreased from 114.05 (Mar 24) to 82.29, marking a decrease of 31.76.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 33.38. It has decreased from 40.68 (Mar 24) to 33.38, marking a decrease of 7.30.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -22.91. This value is below the healthy minimum of 2. It has decreased from -8.20 (Mar 24) to -22.91, marking a decrease of 14.71.
- For PBIT / Share (Rs.), as of Mar 25, the value is -27.23. This value is below the healthy minimum of 0. It has decreased from -10.55 (Mar 24) to -27.23, marking a decrease of 16.68.
- For PBT / Share (Rs.), as of Mar 25, the value is -31.97. This value is below the healthy minimum of 0. It has decreased from -11.61 (Mar 24) to -31.97, marking a decrease of 20.36.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -32.38. This value is below the healthy minimum of 2. It has decreased from -13.31 (Mar 24) to -32.38, marking a decrease of 19.07.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -32.21. This value is below the healthy minimum of 2. It has decreased from -13.06 (Mar 24) to -32.21, marking a decrease of 19.15.
- For PBDIT Margin (%), as of Mar 25, the value is -68.63. This value is below the healthy minimum of 10. It has decreased from -20.15 (Mar 24) to -68.63, marking a decrease of 48.48.
- For PBIT Margin (%), as of Mar 25, the value is -81.57. This value is below the healthy minimum of 10. It has decreased from -25.93 (Mar 24) to -81.57, marking a decrease of 55.64.
- For PBT Margin (%), as of Mar 25, the value is -95.77. This value is below the healthy minimum of 10. It has decreased from -28.53 (Mar 24) to -95.77, marking a decrease of 67.24.
- For Net Profit Margin (%), as of Mar 25, the value is -97.01. This value is below the healthy minimum of 5. It has decreased from -32.71 (Mar 24) to -97.01, marking a decrease of 64.30.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -96.49. This value is below the healthy minimum of 8. It has decreased from -32.10 (Mar 24) to -96.49, marking a decrease of 64.39.
- For Return on Networth / Equity (%), as of Mar 25, the value is -39.14. This value is below the healthy minimum of 15. It has decreased from -11.45 (Mar 24) to -39.14, marking a decrease of 27.69.
- For Return on Capital Employeed (%), as of Mar 25, the value is -25.37. This value is below the healthy minimum of 10. It has decreased from -8.34 (Mar 24) to -25.37, marking a decrease of 17.03.
- For Return On Assets (%), as of Mar 25, the value is -22.18. This value is below the healthy minimum of 5. It has decreased from -8.23 (Mar 24) to -22.18, marking a decrease of 13.95.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.22. It has decreased from 0.24 (Mar 24) to 0.22, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 2.15. This value is within the healthy range. It has decreased from 2.47 (Mar 24) to 2.15, marking a decrease of 0.32.
- For Quick Ratio (X), as of Mar 25, the value is 2.05. This value exceeds the healthy maximum of 2. It has decreased from 2.43 (Mar 24) to 2.05, marking a decrease of 0.38.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 12.78. This value exceeds the healthy maximum of 8. It has increased from 0.46 (Mar 24) to 12.78, marking an increase of 12.32.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -12.39. This value is below the healthy minimum of 3. It has decreased from -7.72 (Mar 24) to -12.39, marking a decrease of 4.67.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -14.95. This value is below the healthy minimum of 3. It has decreased from -11.53 (Mar 24) to -14.95, marking a decrease of 3.42.
- For Enterprise Value (Cr.), as of Mar 25, the value is 694.17. It has increased from 645.65 (Mar 24) to 694.17, marking an increase of 48.52.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.77. This value exceeds the healthy maximum of 3. It has increased from 3.68 (Mar 24) to 4.77, marking an increase of 1.09.
- For EV / EBITDA (X), as of Mar 25, the value is -6.95. This value is below the healthy minimum of 5. It has increased from -18.24 (Mar 24) to -6.95, marking an increase of 11.29.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.51. This value exceeds the healthy maximum of 3. It has increased from 4.86 (Mar 24) to 5.51, marking an increase of 0.65.
- For Price / BV (X), as of Mar 25, the value is 2.24. This value is within the healthy range. It has increased from 1.73 (Mar 24) to 2.24, marking an increase of 0.51.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.51. This value exceeds the healthy maximum of 3. It has increased from 4.86 (Mar 24) to 5.51, marking an increase of 0.65.
- For EarningsYield, as of Mar 25, the value is -0.17. This value is below the healthy minimum of 5. It has decreased from -0.06 (Mar 24) to -0.17, marking a decrease of 0.11.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Max India Ltd:
- Net Profit Margin: -97.01%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -25.37% (Industry Average ROCE: 12.46%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -39.14% (Industry Average ROE: 13.71%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -14.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.05
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 33.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -97.01%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Holding Company | 167, Floor 1, Plot- 167A, Ready Money Mansion, Mumbai Maharashtra 400018 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Analjit Singh | Founder & Chairman |
| Ms. Tara Singh Vachani | Vice Chairperson |
| Mr. Rajit Mehta | Managing Director |
| Mr. Mohit Talwar | Non Executive Director |
| Mr. Pradeep Pant | Independent Director |
| Ms. Sharmila Tagore | Independent Director |
| Dr. Ajit Singh | Independent Director |
| Mr. Niten Malhan | Independent Director |
| Mr. Rohit Kapoor | Independent Director |
FAQ
What is the intrinsic value of Max India Ltd?
Max India Ltd's intrinsic value (as of 04 January 2026) is ₹328.28 which is 74.62% higher the current market price of ₹188.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹985 Cr. market cap, FY2025-2026 high/low of ₹264/160, reserves of ₹415 Cr, and liabilities of ₹838 Cr.
What is the Market Cap of Max India Ltd?
The Market Cap of Max India Ltd is 985 Cr..
What is the current Stock Price of Max India Ltd as on 04 January 2026?
The current stock price of Max India Ltd as on 04 January 2026 is ₹188.
What is the High / Low of Max India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Max India Ltd stocks is ₹264/160.
What is the Stock P/E of Max India Ltd?
The Stock P/E of Max India Ltd is .
What is the Book Value of Max India Ltd?
The Book Value of Max India Ltd is 89.4.
What is the Dividend Yield of Max India Ltd?
The Dividend Yield of Max India Ltd is 0.00 %.
What is the ROCE of Max India Ltd?
The ROCE of Max India Ltd is 23.6 %.
What is the ROE of Max India Ltd?
The ROE of Max India Ltd is 30.0 %.
What is the Face Value of Max India Ltd?
The Face Value of Max India Ltd is 10.0.